Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age

References

• Theodoratou E, Johnson S, Jhass A, et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol. 2010;39(Suppl 1):i172–185.
   PubMedGoogle Scholar
• Principi N, Esposito S. Prevention of community-acquired pneumonia with available pneumococcal vaccines. Int J Mol Sci. 2016;18:30.
   Web of Science ®Google Scholar
• Allison MA, Daley MF, Crane LA, et al. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. J Pediatr. 2006;149:755–762.
   PubMed Web of Science ®Google Scholar
• Kollef MH, Betthauser KD. New antibiotics for community-acquired pneumonia. Curr Opin Infect Dis. 2019;32:169–175.
   PubMed Web of Science ®Google Scholar
• Senstad AC, Surén P, Brauteset L, et al. Community-acquired pneumonia (CAP) in children in Oslo, Norway. Acta Paediatr. 2009;98:332–336.
   PubMed Web of Science ®Google Scholar
• Clark JE, Hammal D, Hampton F, et al. Epidemiology of community-acquired pneumonia in children seen in hospital. Epidemiol Infect. 2007;135:262–269.
   PubMed Web of Science ®Google Scholar
• UNICEF. Pneumonia. [cited 2021 Mar 4]. Available from: https://data.unicef.org/topic/child-health/pneumonia/
   Google Scholar
• British Thoracic Society Paediatric Pneumonia Audit. National audit period: 1 November 2016 – 31 January 2017. [cited 2021 Mar 4]. Available from: file:///C:/Users/nicol/Downloads/Paediatric%20%20Pneumonia%202016_17%20(1).pdf
   Google Scholar
• De Benedictis FM, Kerem E, Chang AB, et al. Complicated pneumonia in children. Lancet. 2020;396:786–798.
   PubMed Web of Science ®Google Scholar
• Fletcher MA, Schmitt HJ, Syrochkina M, et al. Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis. 2014;33:879–910.
   PubMed Web of Science ®Google Scholar
• Wiese AD, Griffin MR, Zhu Y, et al. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. Vaccine. 2016;34:6243–6249.
   PubMed Web of Science ®Google Scholar
• Madhi F, Levy C, Morin L, et al. Change in bacterial causes of community-acquired parapneumonic effusion and pleural empyema in children 6 years after 13-Valent pneumococcal conjugate vaccine implementation. J Pediatric Infect Dis Soc. 2019;8:474–477.
   PubMed Web of Science ®Google Scholar
• Nath S, Thomas M, Spencer D, et al. Has the incidence of empyema in Scottish children continued to increase beyond 2005? Arch Dis Child. 2015;100:255–258.
   PubMed Web of Science ®Google Scholar
• Picazo J, Ruiz-Contreras J, Casado-Flores J, et al. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011. Pediatr Infect Dis J. 2013;32:656–661.
   PubMed Web of Science ®Google Scholar
• Lindstrand A, Bennet R, Galanis I, et al. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine. Pediatrics. 2014;134:e1528–1536.
   PubMed Web of Science ®Google Scholar
• López EL, Glatstein E, Ezcurra GC, et al. Rapid decrease in rates of hospitalization resulting from invasive pneumococcal disease and community-acquired pneumonia in children aged <60 months after 13-valent pneumococcal conjugate vaccine introduction in argentina. J Pediatric Infect Dis Soc. 2018;7:30–35.
   PubMed Web of Science ®Google Scholar
• Strachan R, Homaira N, Beggs S, et al. Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax. 2021;76(5):487–493. Epub Jan 27:thoraxjnl-2020-216032.
   PubMed Web of Science ®Google Scholar
• Syrogiannopoulos GA, Michoula AN, Tsimitselis G, et al. Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine. Infect Dis (Lond). 2016;48:749–753.
   PubMed Web of Science ®Google Scholar
• Goettler D, Streng A, Kemmling D, et al. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany. Vaccine. 2020;38:570–577.
   PubMed Web of Science ®Google Scholar
• Olarte L, Barson WJ, Barson RM. Pneumococcal pneumonia requiring hospitalization in US children in the 13-Valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2017;64:1699–1704.
   PubMed Web of Science ®Google Scholar
• Carloni I, Ricci S, Rubino C, et al. Necrotizing pneumonia among Italian children in the pneumococcal conjugate vaccine era. Pediatr Pulmonol. 2021;56(5):1127–1135. Epub Jan 14.
   PubMed Web of Science ®Google Scholar
• Andrews N, Kent A, Amin-Chowdhury Z, et al. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: the indirect cohort design, 2006-2018. Vaccine. 2019;37:4491–4498.
   PubMed Web of Science ®Google Scholar
• Lapidot R, Shea KM, Yildirim I, et al. Department of public health TM. Characteristics of Serotype 3 invasive pneumococcal disease before and after universal childhood immunization with PCV13 in Massachusetts. Pathogens. 2020;9:396.
   Web of Science ®Google Scholar
• Luck JN, Tettelin H, Orihuela CJ. Sugar-coated killer: serotype 3 pneumococcal disease. Front Cell Infect Microbiol. 2020;10:613287.
   PubMed Web of Science ®Google Scholar
• Andrews NJ, Waight PA, Burbidge P, et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14:839–846.
   PubMed Web of Science ®Google Scholar
• Platt HL, Greenberg D, Tapiero B, et al. A Phase II trial of safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in healthy infants. Pediatr Infect Dis J. 2020;39:763–770.
   PubMed Web of Science ®Google Scholar
• Masomian M, Ahmad Z, Gew LT, et al. Development of next generation streptococcus pneumoniae vaccines conferring broad protection. Vaccines (Basel). 2020;8:132.
   Web of Science ®Google Scholar
• Esposito S, Cohen R, Domingo JD, et al. Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J. 2012;31:e78–85.
   PubMed Web of Science ®Google Scholar
• Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25–76.
   PubMed Web of Science ®Google Scholar
• Hallifax RJ, Talwar A, Wrightson JM, et al. State-of-the-art: radiological investigation of pleural disease. Respir Med. 2017;124:88–99.
   PubMed Web of Science ®Google Scholar
• Blackmore CC, Black WC, Dallas RV, et al. Pleural fluid volume estimation: a chest radiograph prediction rule. Acad Radiol. 1996;3:103–109.
   PubMed Web of Science ®Google Scholar
• Balfour-Lynn IM, Abrahamson E, Cohen G, et al. Paediatric pleural diseases subcommittee of the BTS standards of care committee. BTS guidelines for the management of pleural infection in children. Thorax. 2005;60(Suppl 1):i1–21.
   PubMedGoogle Scholar
• Calder A, Owens CM. Imaging of parapneumonic pleural effusions and empyema in children. Pediatr Radiol. 2009;39:527–537. Soares P, Barreira J, Pissarra S, et al. Pediatric parapneumonic pleural effusions: experience in a university central hospital. Rev Port Pneumol. 2009;15:241-259.
   PubMed Web of Science ®Google Scholar
• Bobillo-Perez S, Girona-Alarcon M, Rodriguez-Fanjul J, et al. Lung ultrasound in children: what does it give us? Pediatr Resp Rev. 2020;36:136–141.
   PubMed Web of Science ®Google Scholar
• Yang PC, Luh KT, Chang DB, et al. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol. 1992;159:29–33.
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Emerging problems in the treatment of pediatric community-acquired pneumonia. Expert Rev Respir Med. 2018;12:595–603.
   PubMed Web of Science ®Google Scholar
• Stadler JAM, Andronikou S, Zar HJ. Lung ultrasound for the diagnosis of community-acquired pneumonia in children. Pediatr Radiol. 2017;47:1412–1419.
   PubMed Web of Science ®Google Scholar
• Karkhanis VS, Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open Access Emerg Med. 2012;4:31–52.
   PubMedGoogle Scholar
• Principi N, Esposito A, Giannitto C, et al. Lung ultrasonography to diagnose community-acquired pneumonia in children. BMC Pulm Med. 2017;17:212.
   PubMed Web of Science ®Google Scholar
• Lahti E, Peltola V, Virkki R, et al. Development of parapneumonic empyema in children. Acta Paediatr. 2007;96:1686–1692.
   PubMed Web of Science ®Google Scholar
• Amorim PG, Morcillo AM, Tresoldi AT, et al. Factors associated with complications of community‐acquired pneumonia in preschool children. J Bras Pneumol. 2012;38:614–621.
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax. 2011;66:815–822.
   PubMed Web of Science ®Google Scholar
• Osowicki J, Kapur S, Phuong LK, et al. The long shadow of Lemierre’s syndrome. J Infect. 2017;74(suppl 1):S47–S53.
   PubMedGoogle Scholar
• Tan Kendrick AP, Ling H, Subramaniam R, et al. The value of early CT in complicated childhood pneumonia. Pediatr Radiol. 2002;32:16–21.
   PubMed Web of Science ®Google Scholar
• Jaffe A, Calder AD, Owens CM, et al. Role of routine computed tomography in paediatric pleural empyema. Thorax. 2008;63:897–902.
   PubMed Web of Science ®Google Scholar
• Andronikou S, Goussard P, Sorantin E. Computed tomography in children with community-acquired pneumonia. Pediatr Radiol. 2017;47:1431–1440.
   PubMed Web of Science ®Google Scholar
• Light RW, Rodriguez RM. Management of parapneumonic effusions. Clin Chest Med. 1998;19:373–382.
   PubMed Web of Science ®Google Scholar
• Balfour-Lynn IM, Abrahamson E, Cohen G, et al. BTS guidelines for the management of pleural infection in children. Thorax. 2005;60(Suppl.1):i1–i21.
   PubMedGoogle Scholar
• Strachan RE, Jaffe A. Recommendations for managing paediatric empyema thoracis. Med J Aust. 2011;195:95.
   PubMed Web of Science ®Google Scholar
• Carter E, Waldhausen J, Zhang W, et al. Management of children with empyema: pleural drainage is not always necessary. Pediatr Pulmonol. 2010;45:475–480.
   PubMed Web of Science ®Google Scholar
• Islam S, Calkins CM, Goldin AB, et al. The diagnosis and management of empyema in children: a comprehensive review from the APSA Outcomes and Clinical Trials Committee. J Pediatr Surg. 2012;47:2101–2110.
   PubMed Web of Science ®Google Scholar
• Bueno Fischer G, Teresinha Mocelin H, Feijó Andrade C, et al. When should parapneumonic pleural effusions be drained in children? Paediatr Respir Rev. 2018;26:27–30.
   PubMed Web of Science ®Google Scholar
• Esposito S, Principi N. Defining the aetiology of paediatric community-acquired pneumonia: an unsolved problem. Expert Rev Respir Med. 2019;13:153–161.
   PubMed Web of Science ®Google Scholar
• Krenke K, Sadowy E, Podsiadły E, et al. Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests. Respir Med. 2016;116:28–33.
   PubMed Web of Science ®Google Scholar
• Obando I, Camacho-Lovillo MS, Porras A, et al. Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009. Clin Microbiol Infect. 2012;18:763–768.
   PubMed Web of Science ®Google Scholar
• Cilloniz C, Liapikou A, Torres A. Advances in molecular diagnostic tests for pneumonia. Curr Opin Pulm Med. 2020;26:241–248.
   PubMed Web of Science ®Google Scholar
• Johansson N, Kalin M, Giske CG, et al. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis. 2008;60:255–261.
   PubMed Web of Science ®Google Scholar
• Strålin K, Törnqvist E, Kaltoft MS, et al. Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol. 2006;44:643–645.
   PubMed Web of Science ®Google Scholar
• Resti M, Moriondo M, Cortimiglia M, et al. Community‐acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real‐time polymerase chain reaction using blood samples. Clin Infect Dis. 2010;51:1042–1049.
   PubMed Web of Science ®Google Scholar
• Taryle DA, Good JT, Morgan EJ, et al. Antibiotic concentrations in human parapneumonic effusions. Antimicrob Agents Chemother. 1981;7:171–177.
   Google Scholar
• Hughes CE, Vanscoy RE. Antibiotic therapy of pleural empyema. Semin Respir Infect. 1991;6:94–102.
   PubMedGoogle Scholar
• Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007;45:1480–1486.
   PubMed Web of Science ®Google Scholar
• Liese JG, Schoen C, van der Linden M, et al. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study. Clin Microbiol Infect. 2019;25:857–864.
   PubMed Web of Science ®Google Scholar
• Krenke K, Sadowy E, Podsiadły E, et al. Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests. Respir Med. 2016 Jul;116:28–33.
   PubMed Web of Science ®Google Scholar
• Lin TY, Hwang KP, Liu CC, et al. Etiology of empyema thoracis and parapneumonic pleural effusion in Taiwanese children and adolescents younger than 18 years of age. Pediatr Infect Dis J. 2013;32:419–421.
   PubMed Web of Science ®Google Scholar
• Patradoon-Ho P, Fitzgerald DA. Lung abscess in children. Paediatr Respir Rev. 2007;8:77–84.
   PubMed Web of Science ®Google Scholar
• Masters IB, Isles AF, Grimwood K. Necrotizing pneumonia: an emerging problem in children? Pneumonia (Nathan). 2017;9:11.
   PubMedGoogle Scholar
• Angurana SK, Kumar R, Singh M, et al. Pediatric empyema thoracis: what has changed over a decade? J Trop Pediatr. 2019 Jun 1;65(3):231–239.
   PubMed Web of Science ®Google Scholar
• Chacon-Cruz E, Rivas-Landeros RM, Volker-Soberanes ML, et al. 12 years active surveillance for pediatric pleural empyema in a Mexican hospital: effectiveness of pneumococcal 13-valent conjugate vaccine, and early emergence of methicillin-resistant Staphylococcus aureus. Ther Adv Infect Dis. 2019;6:2049936119839312.
   Web of Science ®Google Scholar
• Osowicki J, Steer AC. International survey of paediatric infectious diseases consultants on the management of community-acquired pneumonia complicated by pleural empyema. J Paediatr Child Health. 2019;55:66–73.
   PubMed Web of Science ®Google Scholar
• Tong SYC, Lye DC, Yahav D, et al. Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-Lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial. JAMA. 2020;323:527–537.
   PubMed Web of Science ®Google Scholar
• Blumer JL, Ghonghadze T, Cannavino C, et al. A multicenter, randomized, observer-blinded, active-controlled study evaluating the safety and effectiveness of ceftaroline compared with ceftriaxone plus vancomycin in pediatric patients with complicated community-acquired bacterial pneumonia. Pediatr Infect Dis J. 2016;35:760–766.
   PubMed Web of Science ®Google Scholar